At the moment, most clinical trial plans follow ICH pointers, aimed toward "ensuring that top quality, Safe and sound and helpful medicines are produced and registered in the most economical and cost-effective method. These activities are pursued from the interest of the consumer and public health, to prevent avoidable duplication of clinical trial